- €131.27m
- €965.22m
- €76.61m
- 32
- 56
- 16
- 24
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 83.4 | 84.9 | 84.9 | 78 | 76.6 |
Cost of Revenue | |||||
Gross Profit | 61.9 | 63.3 | 63.7 | 49.4 | 50.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -10.9 | 56 | 38.1 | 104 | 264 |
Operating Profit | 94.3 | 28.9 | 46.9 | -25.7 | -188 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 80.8 | 16.1 | 36.9 | -4.18 | -240 |
Provision for Income Taxes | |||||
Net Income After Taxes | 80.8 | 16.1 | 36.9 | -4.18 | -240 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 80.8 | 16.1 | 36.9 | -4.18 | -240 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 80.6 | 16.1 | 36.9 | -4.18 | -240 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.91 | 0.98 | 2.21 | -0.246 | -14.1 |
Dividends per Share |